United States · Startup
United States · Gallant Pet, Inc.
Gallant Therapeutics is a California-based biotechnology company that develops and commercializes stem cell therapeutics to diagnose the root cause of major diseases in pets.
Funding reportedLast round: Series A
What company datasets say Gallant Pet, Inc. raised
Funding, as reported
Reported in all$15Min dollars
Last roundSeries A
Last round size$15M
Last round dateJan 2024
Founders and team
From Gallant Pet, Inc.'s own website: 6 on the team.
- Beau BeckerHead of Strategic Operations & People Effectiveness
- Aaron SchachtBoard Member
- Darryl RawlingsBoard Member
- Doug DrewBoard Member
- Richard D. JenningsBoard Member
- Teymour Boutros-GhaliChairman of the Board
On a portfolio page
Investors who name them
Each firm lists Gallant Pet, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Is this your company?
Add your raise, your deck and your story, and put Gallant Pet, Inc. in front of investors. Or tell us what we have wrong.